Inflammatory breast cancer biology: the tumour microenvironment is key | Nature Reviews Cancer
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway | Nature
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs | Nature Reviews Clinical Oncology
A role for chromatin regulatory dynamics in breast cancer evolution | Nature Medicine
Breast cancer | Nature Reviews Disease Primers
Breast cancer | Nature Reviews Disease Primers
Breast cancer | Nature Reviews Disease Primers
Clinical overview of metronomic chemotherapy in breast cancer | Nature Reviews Clinical Oncology
Breast cancer metastasis: markers and models | Nature Reviews Cancer
Comprehensive molecular portraits of human breast tumours | Nature
Biological determinants of endocrine resistance in breast cancer | Nature Reviews Cancer
Breast cancer metastasis: markers and models | Nature Reviews Cancer
Breast cancer | Nature Reviews Disease Primers
Precision medicine for metastatic breast cancer—limitations and solutions | Nature Reviews Clinical Oncology
Breast tumor microenvironment structures are associated with genomic features and clinical outcome | Nature Genetics
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells | Nature
Breast cancer | Nature Reviews Disease Primers
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease | Nature Reviews Clinical Oncology
Breast cancer | Nature Reviews Disease Primers
Key steps for effective breast cancer prevention | Nature Reviews Cancer
Modelling breast cancer: one size does not fit all | Nature Reviews Cancer
Breast cancer | Nature Reviews Disease Primers
Breast cancer quantitative proteome and proteogenomic landscape | Nature Communications
Nature Reviews Disease Primers on X: "Management of early #breastcancer is based on #tumour burden and subtype - learn more in our Primer https://t.co/3LDzqltJIu #ESMO19 https://t.co/OpB8MBtn12" / X
